NextEd Group Limited (ASX:NXD)

Intra-Cellular Therapies Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	99.14	111.37	102.22	46.82	16.28	10.81
Revenue Growth (YoY)	-15.88%	8.95%	118.33%	187.64%	50.63%	26.50%
Cost of Revenue	47.33	54.09	45.35	18.09	7.24	6.16
Gross Profit	51.81	57.28	56.87	28.73	9.04	4.64
Selling, General & Admin	33.51	36.12	34.05	22.9	6.03	4.82
Other Operating Expenses	3.69	3.69	3.29	2.12	0.75	0.72
Operating Expenses	53.17	56.13	51.18	33.39	8.48	7.6
Operating Income	-1.36	1.15	5.69	-4.66	0.56	-2.96
Interest Expense	-4.02	-4.16	-2.68	-1.62	-0.39	-0.38
Interest & Investment Income	0.55	0.85	0.83	0.01	0	0
Other Non Operating Income (Expenses)	-1.47	-1.47	-0.92	-1.05	0.63	0.53
EBT Excluding Unusual Items	-6.29	-3.63	2.92	-7.32	0.8	-2.81
Merger & Restructuring Charges	-	-	-	-3.24	-0.61	-
Impairment of Goodwill	-22.9	-22.9	-	-	-	-
Asset Writedown	-11.36	-6.03	-	-0.12	-	-
Other Unusual Items	-	-	-	1.48	-	-
Pretax Income	-40.56	-32.55	2.92	-9.2	0.19	-2.81
Income Tax Expense	-1.24	-1.32	-0.69	-0.5	-0.12	-0.17
Net Income	-39.32	-31.23	3.61	-8.7	0.31	-2.64
Net Income to Common	-39.32	-31.23	3.61	-8.7	0.31	-2.64
Shares Outstanding (Basic)	221	221	219	184	112	105
Shares Outstanding (Diluted)	221	221	224	184	112	105
Shares Change (YoY)	-1.71%	-1.18%	21.56%	63.98%	6.74%	3.50%
EPS (Basic)	-0.18	-0.14	0.02	-0.05	0.00	-0.03
EPS (Diluted)	-0.18	-0.14	0.02	-0.05	0.00	-0.03
Free Cash Flow	1.55	-9.23	19.87	8.93	0.3	0.18
Free Cash Flow Per Share	0.01	-0.04	0.09	0.05	0.00	0.00
Gross Margin	52.26%	51.43%	55.63%	61.37%	55.53%	42.97%
Operating Margin	-1.37%	1.03%	5.56%	-9.95%	3.43%	-27.41%
Profit Margin	-39.66%	-28.04%	3.53%	-18.57%	1.89%	-24.43%
Free Cash Flow Margin	1.56%	-8.29%	19.44%	19.07%	1.87%	1.62%
EBITDA	4.75	7.23	10.75	-1.28	1.24	-2.29
EBITDA Margin	4.79%	6.49%	10.52%	-2.73%	7.62%	-21.16%
D&A For EBITDA	6.11	6.08	5.06	3.38	0.68	0.67
EBIT	-1.36	1.15	5.69	-4.66	0.56	-2.96
EBIT Margin	-1.37%	1.03%	5.56%	-9.95%	3.43%	-27.41%

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.